FDA — authorised 27 April 1955
- Application: NDA009866
- Marketing authorisation holder: PHARMACIA AND UPJOHN
- Status: supplemented
FDA authorised Solu-Cortef on 27 April 1955
Yes. FDA authorised it on 27 April 1955.
PHARMACIA AND UPJOHN holds the US marketing authorisation.